INTRODUCTION Granulomatous inflammation is a distinctive ...
INTRODUCTION Granulomatous inflammation is a distinctive ...
INTRODUCTION Granulomatous inflammation is a distinctive ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
(Table 5). Cholesteatomas ar<strong>is</strong>e in similar regions as cholesterol granulomas and are usually<br />
contained within the tympanomastoid region but aggressive lesions do occur with erosion of bone<br />
(Topalogue et al 1997).<br />
CT scan, in both cholesteatomas and cholesterol granulomas, shows a non-specific, non-enhancing<br />
soft t<strong>is</strong>sue mass that has a smooth margin and variable bone erosion (Chang et al., 1998). By MRI,<br />
cholesteatomas are hypointense or <strong>is</strong>ointense on T1-weighted images and hyperintense on T2<br />
images. Cholesterol granulomas typically are homogenous and show bright signal intensity on<br />
both T1- and T2-weighted images without significant enhancement with gadolinium contrast<br />
(lustig et al., 1998). When large, however, cholesterol granulomas can exhibit a more<br />
heterogeneous MRI pattern (Martin et al., 1989).<br />
Table 5. Points of difference between Cholesterol Granulomas and Cholesteatoma (Topalogue et<br />
al 1997)<br />
It <strong>is</strong> important to make the d<strong>is</strong>tinction between cholesterol granuloma and cholesteatoma because<br />
of treatment differences. Cholesterol granulomas will resolve after internal drainage into the<br />
mastoid cavity or middle ear, relieving the obstruction and restoration of the normal<br />
pneumatization of the bone . However, there have been reports of large destructive cholesterol<br />
granulomas that require complete surgical exc<strong>is</strong>ion (Lustig et al., 1998).<br />
DISCUSSION<br />
The granulomatous d<strong>is</strong>orders involving the CNS are a diverse confusing medical problem. They<br />
are assumed to be multifactor difficulties regarding clinical picture, poor investigational yield,<br />
some have controversial treatment and many of them are difficult to be cured if not fatal. The<br />
hallmark for these difficulties <strong>is</strong> the diverse non specific systemic and neurological clinical<br />
presentations for such patients to the extent that many medical specialties face these patients<br />
separately on the first time, and unless the physicians have a high index of clinical suspicion to<br />
such non specific clinical presentations, there will be subsequent delay in diagnos<strong>is</strong> with<br />
deterioration of clinical picture making the management of poor outcome.<br />
Furthermore, each of these d<strong>is</strong>eases has its own diagnostic workup on one hand and most of the